Charles Haaser
Director of Finance/CFO at YIELD10 BIOSCIENCE, INC.
Net worth: 53 527 $ as of 2024-03-30
Profile
Charles B.
Haaser's career history includes current and former positions as well as education.
Currently, he is the Chief Accounting Officer, Treasurer & VP-Finance at Yield10.
Bioscience, Inc. He started this position in 2016.
Previously, he worked as the Finance Director at ISI Systems, Inc. from 1986 to 1997.
From 1998 to 2006, he served as the Controller, Chief Accounting & Financial Officer at ABIOMED, Inc. Following that, he was the Corporate Controller at Indevus Pharmaceuticals, Inc. from 2006 to 2008.
Additionally, he worked as the Controller at Technical Communications Corp.
from 1986 to 1998.
Mr. Haaser also has experience as an Auditor at PricewaterhouseCoopers LLP.
In terms of education, he completed his undergraduate degree at the University of Notre Dame, his graduate degree at Bentley University, and his MBA at Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
1.18% | 2024-02-14 | 140,861 ( 1.18% ) | 53 527 $ | 2024-03-30 |
Charles Haaser active positions
| Companies | Position | Start |
|---|---|---|
| YIELD10 BIOSCIENCE, INC. | Director of Finance/CFO | 2014-11-02 |
Former positions of Charles Haaser
| Companies | Position | End |
|---|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Comptroller/Controller/Auditor | 2007-12-31 |
| ABIOMED, INC. | Director of Finance/CFO | 2006-05-29 |
| TECHNICAL COMMUNICATIONS CORPORATION | Comptroller/Controller/Auditor | 1997-12-31 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Training of Charles Haaser
| University of Notre Dame | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
| Bentley University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TECHNICAL COMMUNICATIONS CORPORATION | Industrial Services |
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| Private companies | 3 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Stock Market
- Insiders
- Charles Haaser
